Rabies vaccine
- Generic Name
- Rabies vaccine
Safety and Immunogenicity of a Candidate Rift Valley Fever Vaccine (RVF003)
Phase 2
Not yet recruiting
- Conditions
- Rift Valley Fever
- Interventions
- First Posted Date
- 2025-01-29
- Last Posted Date
- 2025-01-29
- Lead Sponsor
- University of Oxford
- Target Recruit Count
- 240
- Registration Number
- NCT06799234
- Locations
- 🇰🇪
KEMRI-Wellcome Trust Research Programme, Kilifi, Coast, Kenya
Study to Evaluate GR1801's Efficacy and Safety
Phase 3
Recruiting
- Conditions
- Rabies Post-exposure Prophylaxis
- Interventions
- First Posted Date
- 2023-05-06
- Last Posted Date
- 2023-09-21
- Lead Sponsor
- Genrix (Shanghai) Biopharmaceutical Co., Ltd.
- Target Recruit Count
- 1200
- Registration Number
- NCT05846568
- Locations
- 🇨🇳
Center for Disease Control and Prevention (CDC), Kunming, Yunnan, China
A Study to Test Experimental Blood Stage Malaria Vaccine in Burkina Faso.
Phase 1
Recruiting
- Conditions
- Malaria,Falciparum
- Interventions
- Biological: RH5.1 10μg adjuvated with 50μg Matrix-MBiological: RH5.2 5μg adjuvated with 50μg Matrix-M
- First Posted Date
- 2023-03-30
- Last Posted Date
- 2025-03-07
- Lead Sponsor
- University of Oxford
- Target Recruit Count
- 480
- Registration Number
- NCT05790889
- Locations
- 🇧🇫
Institut de Recherche en Sciences de la Santé, Sigle, Boulkiemdé Province, Burkina Faso
Vaccine Responsiveness After CAR-T Cell Therapy
Phase 1
Active, not recruiting
- Conditions
- B-Cell Neoplasm
- Interventions
- Procedure: Biospecimen Collection
- First Posted Date
- 2020-06-01
- Last Posted Date
- 2025-03-24
- Lead Sponsor
- Fred Hutchinson Cancer Center
- Target Recruit Count
- 49
- Registration Number
- NCT04410900
- Locations
- 🇺🇸
Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, United States
Immunogenicity of Rabies Vaccine for Pre Exposure Prophylaxis
- First Posted Date
- 2015-03-02
- Last Posted Date
- 2022-06-13
- Lead Sponsor
- State University of New York - Upstate Medical University
- Target Recruit Count
- 60
- Registration Number
- NCT02374814
- Locations
- 🇺🇸
State University of New York, Upstate Medical University (SUNY-UMU), Syracuse, New York, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath